Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-25

Clinical Trial Update: Smell, Voice and Nasal Swabs as Markers for Neuro-degenerative Disorders [NA]

View source ↗

Summary

Clinical trial update on using smell, voice, and nasal swabs as markers for neuro-degenerative disorders; status completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Arkansas | Conditions: Alzheimer Disease, Neurodegenerative Diseases | NA | Status: COMPLETED | Results posted: 2022-11-25